Development and validation of the Vaccine Barriers Assessment Tool for identifying drivers of under-vaccination in children under five years in Australia
Jessica Kaufman Jane Tuckerman Carissa Bonner David N. Durrheim Daniel S. J.3 Costa Lyndal Trevena Jörg Henseler Margie Danchin a Vaccine Uptake Group,Murdoch Children's Research Institute,Royal Children's Hospital,Parkville,Australiab Department of Paediatrics,The University of Melbourne,Royal Children's Hospital,Parkville,Australiac School of Public Health,University of Sydney,Camperdown,Australiad School of Medicine and Public Health,University of Newcastle,University Drive,Callaghan,Australiae Health Protection,Hunter New England Population Health,Wallsend,Australiaf School of Psychology,University of Sydney,Camperdown,Australiag Department of Design,Production & Management,University of Twente,Enschede,Netherlandsh Nova Information Management School,Universidade Nova de Lisboa,Lisbon,Portugali Department of General Medicine,Royal Children's Hospital,Parkville,Australia
DOI: https://doi.org/10.1080/21645515.2024.2359623
2024-06-08
Human Vaccines & Immunotherapeutics
Abstract:Data on routine childhood vaccination coverage can only tell us who is under-vaccinated; it cannot explain why vaccine coverage is low. Collecting data on the reasons behind under-vaccination is necessary to implement cost-effective strategies that address key barriers and target interventions appropriately. However, no instruments that measure both vaccine acceptance and access factors among parents of children <5 y have been validated in high-income countries. This study aims to develop and validate the Vaccine Barriers Assessment Tool (VBAT) for Australia. We applied three phases of mixed methods data collection and analysis. In Phase 1, we developed a comprehensive list of 80 items reflecting all potential parental barriers to childhood vaccination, derived from published literature and behavioral theory. Through cognitive interviews ( n = 28), we refined this list to 45 items. In Phase 2, we conducted a two-wave online survey to test the reliability and validity of these items in an Australian sample of parents ( n = 532) with structural equation modeling, further refining the list to 35 items. In Phase 3, we conducted a final parent survey ( n = 156), administering these items along with the Parent Attitudes toward Childhood Vaccination (PACV) scale for comparison. We reviewed participants' immunization register data to assess the predictive validity of the proposed models. The final 6-item short form and 15-item long form Vaccine Barriers Assessment Tool assess access, communal benefit, personal risk, equity, commitment, social norms, and trust in health-care workers. It is being applied for national surveillance in Australia and will be adapted for additional populations and vaccines.
immunology,biotechnology & applied microbiology